FDA ‘Actively Investigating’ Asbestos In Cosmetics; Claire’s Rebuts New Allegations
This article was originally published in The Rose Sheet
Executive Summary
Health Canada’s investigation cleared Claire’s makeup previously linked to asbestos by Scientific Analytical Institute, the same lab whose asbestos findings Tween Brands disputed last year before launching a recall based on its own testing. Cosmetics manufacturers using talc should try to keep up.
You may also be interested in...
FDA To Hold Public Meeting In February on Cosmetic Talc-Asbestos Test Methods
Recommendations from an FDA-led interagency work group regarding methods for detecting and measuring asbestos in talc and talc-containing cosmetics will be presented at the agency’s planned public meeting in Silver Spring, MD, on 4 February. The recommendations are summarized in the FDA's meeting notice, which follows contentious cosmetic product recalls based on asbestos findings.
J&J Doing Damage Control Following Reuters Report On Asbestos ‘Lurking’ In Johnson’s Powder
J&J shares are down nearly 12% since Reuters reported Dec. 14 that the firm has known for decades about toxic asbestos in its Johnson’s Baby Powder talc. The news outlet’s probe turned up nothing that hasn’t been raised by plaintiff attorneys, but throws the central issues of contention into high relief for its global audience.
FDA Shopping For 3D Tissue Bioprinter, Cosmetic Contamination Testing Services
Recent procurement activities show an agency increasingly focused on cosmetics’ safety vis-a-vis microbial threats and, in the case of talc-containing products, asbestos. Meanwhile, FDA seeks a 3D bioprinter to use in organ toxicity studies as an alternative to traditional animal models.